top of page
Main pulmonary artery diameter predicts risk in PAH patients
Researchers wanted to know whether an enlarged pulmonary artery could independently predict risk in pulmonary arterial hypertension (in...
PHA Canada
Mar 311 min read
Â
Â
Â


Two tips for tax season
Tax season is upon us! The pulmonary hypertension community brought two tips to our attention. First, the usual disclaimer: we are not...
PHA Canada
Mar 251 min read
Â
Â
Â
Plain-language summary available for the TORREY seralutinib study
Seralutinib is a molecule that blocks inflammation, cell proliferation, and scarring responsible for pulmonary arterial hypertension. The...
PHA Canada
Mar 171 min read
Â
Â


A Canadian Initiative: Exploring Adult Pulmonary Hypertension
New Report Sheds Light on Pulmonary Hypertension in Canada Respiplus has just released a groundbreaking report, A Canadian Initiative:...
PHA Canada
Mar 131 min read
Â
Â
Â
Did you know Canada has a Caregiver Tax Credit?
Many people know about Canada’s Disability Tax Credit, but did you know that there is also a non-refundable tax credit for caregivers? If...
PHA Canada
Mar 41 min read
Â
Â
Â
PAH patients who skip treatment don't do as well as patients who adhere to their treatment plan
In a study of data from the Pulmonary Hypertension Association Registry in the US, researchers looked at who was more likely to skip...
PHA Canada
Mar 31 min read
Â
Â


New Faces, Lasting Connections: My First PH Conference Experience
The 2024 Pulmonary Hypertension Patient Symposium in Calgary was my first rodeo, as it were. I started dating my partner Tarya in the...
Simon Goring
Feb 193 min read
Â
Â
Â
Newly diagnosed PAH patients on triple therapy have fewer hospitalizations vs. double therapy
A study looked at about 3000 pulmonary arterial hypertension patients and found that people who added selexipag to double therapy (an...
PHA Canada
Feb 181 min read
Â
Â
HYPERION sotatercept study has positive results, stops early
The HYPERION study examined whether adding sotatercept to other therapies for recently diagnosed patients with pulmonary arterial...
PHA Canada
Feb 101 min read
Â
Â
Â
Treprostinil benefits PAH patients with cardiovascular issues
Patients with pulmonary arterial hypertension (PAH) often also have cardiovascular issues such as diabetes or heart disease. A new...
PHA Canada
Feb 41 min read
Â
Â
Â
Op-ed: Speed up patient access to life-saving medications
"Imagine being told that a new treatment exists — one that could save your life or significantly improve it — but that you’ll have to...
PHA Canada
Jan 281 min read
Â
Â
Â


Patient Voice: Angel's Story
Angel Ouellet One day when I was six years old, I saw a favourite teacher at the end of the corridor at school and ran to give them a...
Patient Voice
Jan 162 min read
Â
Â
Â


Patient Voice: Rose's Story
Rose Jardim When I was 50 years old, I cut myself while shaving my legs. And then the cut just didn’t heal. It developed into a deep...
Patient Voice
Jan 162 min read
Â
Â
Â


Patient Voice: Tarya's Story
Tarya Morel Looking back, I’ve had difficulties with shortness of breath for as long as I can remember, but it never really occurred to...
Patient Voice
Jan 162 min read
Â
Â
Â
Sotatercept safe and effective across cardiac index groups
Cardiac index (CI) assesses the output of someone's heart based on their size. It measures heart function relative to the person's size...
PHA Canada
Dec 18, 20241 min read
Â
Â
Â
Take Action to Support Canadian Charities
The holiday season is the most critical fundraising period for charities, with many relying on year-end donations to sustain their work....
PHA Canada
Dec 17, 20241 min read
Â
Â
Â
A Simple Step to Save Lives: Ontario's Tax Return Initiative for Organ Donation
In an innovative new collaboration between Trillium Gift of Life Network (TGLN) and the provincial and federal governments, millions of...
PHA Canada
Dec 10, 20241 min read
Â
Â
Â
Pulmonary Hypertension Association of Canada Urges Québec's Minister of Health to Join pCPA Negotiations for Sotatercept
INESSS recognizes sotatercept's therapeutic value but recommends against public funding Vancouver BC (5 December 2024) -- The Pulmonary...
PHA Canada
Dec 6, 20242 min read
Â
Â
Â
Improved reimbursements for PH patients in Northern Ontario
As of December 1, the Ontario government has improved reimbursement amounts for people in Northern Ontario who need to travel for...
PHA Canada
Dec 4, 20241 min read
Â
Â
Â
ZENITH study shows sotatercept is effective for PAH patients at high risk of mortality
The ZENITH study examined whether adding sotatercept to people's ongoing therapies reduced the risk of death, lung transplantation, or...
PHA Canada
Nov 26, 20241 min read
Â
Â
Â
bottom of page
